Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-05 03:36 | 2024-01-02 | PEN | Penumbra Inc | Sarna Surbhi | Director | Surgical & Medical Instruments & Apparatus | SALE | $247.68 | 85 | $21,053 | 2,295 | -3.6% |
| 2023-10-05 02:34 | 2023-10-02 | PEN | Penumbra Inc | Sarna Surbhi | Director | Surgical & Medical Instruments & Apparatus | SALE | $240.99 | 85 | $20,484 | 2,380 | -3.4% |
| 2023-09-07 03:01 | 2023-09-01 | PEN | Penumbra Inc | Sarna Surbhi | Director | Surgical & Medical Instruments & Apparatus | SALE | $266.62 | 85 | $22,663 | 2,465 | -3.3% |
| 2023-07-07 03:23 | 2023-07-03 | PEN | Penumbra Inc | Sarna Surbhi | Director | Surgical & Medical Instruments & Apparatus | SALE | $341.45 | 27 | $9,219 | 2,550 | -1.0% |
| 2023-04-06 02:31 | 2023-04-03 | PEN | Penumbra Inc | Sarna Surbhi | Director | Surgical & Medical Instruments & Apparatus | SALE | $276.37 | 28 | $7,738 | 2,577 | -1.1% |
| 2023-01-06 03:05 | 2023-01-03 | PEN | Penumbra Inc | Sarna Surbhi | Director | Surgical & Medical Instruments & Apparatus | SALE | $227.12 | 27 | $6,132 | 1,925 | -1.4% |
| 2022-10-06 03:32 | 2022-10-03 | PEN | Penumbra Inc | Sarna Surbhi | Director | Surgical & Medical Instruments & Apparatus | SALE | $191.20 | 28 | $5,354 | 1,952 | -1.4% |
| 2022-07-07 03:26 | 2022-07-01 | PEN | Penumbra Inc | Sarna Surbhi | Director | Surgical & Medical Instruments & Apparatus | SALE | $124.39 | 27 | $3,359 | 1,980 | -1.3% |
| 2022-07-06 01:48 | 2022-07-05 | BIOR | N/A | Sarna Surbhi | Director | Other | SALE | $0.61 | 7,517 | $4,585 | 148,774 | -4.8% |
| 2022-04-06 02:50 | 2022-04-01 | PEN | Penumbra Inc | Sarna Surbhi | Director | Surgical & Medical Instruments & Apparatus | SALE | $221.71 | 28 | $6,208 | 2,007 | -1.4% |
| 2022-01-06 03:46 | 2022-01-03 | PEN | Penumbra Inc | Sarna Surbhi | Director | Surgical & Medical Instruments & Apparatus | SALE | $285.34 | 94 | $26,822 | 1,325 | -6.6% |
| 2021-11-03 02:47 | 2021-11-01 | PEN | Penumbra Inc | Sarna Surbhi | Director | Surgical & Medical Instruments & Apparatus | SALE | $278.06 | 907 | $252,200 | 1,419 | -39.0% |
| 2020-01-30 04:04 | 2020-01-27 | PEN | Penumbra Inc | Sarna Surbhi | Director | Surgical & Medical Instruments & Apparatus | SALE | $168.79 | 273 | $46,080 | 1,035 | -20.9% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.